Skip to main content
SpringerLink
Log in

False-negative 18F-PSMA-1007 PET/CT in metastatic prostate cancer related to high physiologic liver uptake

  • Image of the Month
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hofman MS, Violet J, Hicks RJ, Ferdinandus J, Thang SP, Akhurst T, et al. [(177)Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study. Lancet Oncol. 2018;19(6):825–33.

    Article  CAS  Google Scholar 

  2. Thang SP, Violet J, Sandhu S, Iravani A, Akhurst T, Kong G, et al. Poor outcomes for patients with metastatic castration-resistant prostate cancer with low prostate-specific membrane antigen (PSMA) expression deemed ineligible for (177)Lu-labelled PSMA radioligand therapy. Eur Urol Oncol. 2018.

  3. Giesel FL, Hadaschik B, Cardinale J, Radtke J, Vinsensia M, Lehnert W, et al. F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients. Eur J Nucl Med Mol Imaging. 2017;44(4):678–88.

    Article  CAS  Google Scholar 

  4. Kessel K, Seifert R, Schafers M, Weckesser M, Schlack K, Boegemann M, et al. Second line chemotherapy and visceral metastases are associated with poor survival in patients with mCRPC receiving (177)Lu-PSMA-617. Theranostics. 2019;9(17):4841–8.

    Article  CAS  Google Scholar 

  5. Kratochwil C, Fendler WP, Eiber M, Baum R, Bozkurt MF, Czernin J, et al. EANM procedure guidelines for radionuclide therapy with (177)Lu-labelled PSMA-ligands ((177)Lu-PSMA-RLT). Eur J Nucl Med Mol Imaging. 2019.

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany

    Philipp E. Hartrampf, Andreas K. Buck & Constantin Lapa

  2. Department of Urology and Paediatric Urology, University Hospital Würzburg, Würzburg, Germany

    Anna Katharina Seitz & Markus Krebs

  3. Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany

    Markus Krebs

  4. Department of Nuclear Medicine, University Hospital Augsburg, Augsburg, Germany

    Constantin Lapa

Authors
  1. Philipp E. Hartrampf
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anna Katharina Seitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Markus Krebs
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Andreas K. Buck
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Constantin Lapa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Constantin Lapa.

Ethics declarations

Informed consent from the patient for publication of this case study was obtained.

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Oncology – Genitourinary

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hartrampf, P.E., Seitz, A.K., Krebs, M. et al. False-negative 18F-PSMA-1007 PET/CT in metastatic prostate cancer related to high physiologic liver uptake. Eur J Nucl Med Mol Imaging 47, 2044–2046 (2020). https://doi.org/10.1007/s00259-019-04645-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-019-04645-5

Search

Navigation